| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Zubin Bhagwagar, Rainer Hinz, Matthew Taylor, Sabrina Fancy, Philip Cowen, Paul Grasb. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. The American journal of psychiatry. vol 163. issue 9. 2006-10-05. PMID:16946184. |
increased 5-ht(2a) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)c]mdl 100,907. |
2006-10-05 |
2023-08-12 |
human |
| Zubin Bhagwagar, Rainer Hinz, Matthew Taylor, Sabrina Fancy, Philip Cowen, Paul Grasb. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. The American journal of psychiatry. vol 163. issue 9. 2006-10-05. PMID:16946184. |
the purpose of the present study was to use the highly selective 5-ht(2a) receptor ligand [(11)c]mdl 100,907 in a pet imaging paradigm to assess 1) 5-ht(2a) receptor binding potential in euthymic subjects with a history of recurrent depression and 2) the relationship between receptor binding and scores on the dysfunctional attitudes scale. |
2006-10-05 |
2023-08-12 |
human |
| Gil Zalsman, Yung-Yu Huang, Maria A Oquendo, Ainsley K Burke, Xian-Zhang Hu, David A Brent, Steven P Ellis, David Goldman, J John Man. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. The American journal of psychiatry. vol 163. issue 9. 2006-10-05. PMID:16946185. |
association of a triallelic serotonin transporter gene promoter region (5-httlpr) polymorphism with stressful life events and severity of depression. |
2006-10-05 |
2023-08-12 |
Not clear |
| Gil Zalsman, Yung-Yu Huang, Maria A Oquendo, Ainsley K Burke, Xian-Zhang Hu, David A Brent, Steven P Ellis, David Goldman, J John Man. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. The American journal of psychiatry. vol 163. issue 9. 2006-10-05. PMID:16946185. |
the lower expressing allele of the serotonin transporter gene 5' promoter region (5-httlpr) polymorphism is reported to be associated with susceptibility to depression and suicidality in response to stressful life events. |
2006-10-05 |
2023-08-12 |
Not clear |
| Nora Hanna, Lisa Karabelnik, Jyotsna Rang. Risk of suicide and SSRIs. Connecticut medicine. vol 69. issue 9. 2006-10-04. PMID:16270791. |
the controversy surrounding the use of selective serotonin reuptake inhibitors (ssris), in the treatment of depression and other psychiatric disorders in children and adolescents, has come to the forefront since the question of increased suicidal risk has been raised. |
2006-10-04 |
2023-08-12 |
Not clear |
| Mei Huang, Junji Ichiwaka, Zhu Li, Jin Dai, Herbert Y Meltze. Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex. Psychopharmacology. vol 185. issue 3. 2006-09-29. PMID:16521036. |
olanzapine and risperidone, have been reported to be effective adjunctive treatment for depression if selective serotonin (5-ht) reuptake inhibitors (ssris) alone are ineffective. |
2006-09-29 |
2023-08-12 |
rat |
| Rainald Mössner, Rabi Simantov, Alexander Marx, Klaus Peter Lesch, Isabelle Sei. Aberrant accumulation of serotonin in dopaminergic neurons. Neuroscience letters. vol 401. issue 1-2. 2006-09-28. PMID:16638624. |
these findings have important consequences for antidepressant therapy, since during treatment of depression with selective serotonin reuptake inhibitors, clearance of 5-ht by dopaminergic neurons may reduce the desired therapeutic elevation of extracellular 5-ht levels. |
2006-09-28 |
2023-08-12 |
mouse |
| Panayiota G Michalopoulou, Lefteris Lykoura. Manic/hypomanic symptoms induced by atypical antipsychotics: a review of the reported cases. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 4. 2006-09-25. PMID:16442194. |
on the other hand, atypical aps are also used in combination with (selective) serotonin reuptake inhibitors [(s) sris] in the treatment of resistant depression. |
2006-09-25 |
2023-08-12 |
Not clear |
| Nele Jacobs, Gunter Kenis, Frenk Peeters, Catherine Derom, Robert Vlietinck, Jim van O. Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Archives of general psychiatry. vol 63. issue 9. 2006-09-21. PMID:16953001. |
stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. |
2006-09-21 |
2023-08-12 |
Not clear |
| Taku Sato, Eiji Suzuki, Masamoto Yokoyama, Jun'ichi Semba, Shigeru Watanabe, Hitoshi Miyaok. Chronic intraperitoneal injection of interferon-alpha reduces serotonin levels in various regions of rat brain, but does not change levels of serotonin transporter mRNA, nitrite or nitrate. Psychiatry and clinical neurosciences. vol 60. issue 4. 2006-09-20. PMID:16884454. |
further investigation is needed to determine exactly how this cytokine affects the central serotonin system and to assess whether a central serotonin abnormality is involved in interferon-induced depression. |
2006-09-20 |
2023-08-12 |
rat |
| N Herold, K Uebelhack, L Franke, H Amthauer, L Luedemann, H Bruhn, R Felix, R Uebelhack, M Plotki. Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM. Journal of neural transmission (Vienna, Austria : 1996). vol 113. issue 5. 2006-09-19. PMID:16465456. |
imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel spect ligand [123i]-adam. |
2006-09-19 |
2023-08-12 |
Not clear |
| Sven Ove Ogren, Eugenia Kuteeva, Tomas Hökfelt, Jan Keh. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders. CNS drugs. vol 20. issue 8. 2006-09-19. PMID:16863269. |
accumulated evidence during the last two decades has implicated disturbances in brain serotonin and/or noradrenaline (norepinephrine) neurotransmission in the aetiology of depression. |
2006-09-19 |
2023-08-12 |
mouse |
| Katherine L Wisner, Barbara H Hanusa, James M Perel, Kathleen S Peindl, Catherine M Piontek, Dorothy K Y Sit, Robert L Findling, Eydie L Moses-Kolk. Postpartum depression: a randomized trial of sertraline versus nortriptyline. Journal of clinical psychopharmacology. vol 26. issue 4. 2006-09-18. PMID:16855451. |
symptom reduction and improvement in functioning in women with postpartum major depression treated with a tricyclic antidepressant versus a serotonin reuptake inhibitor were compared. |
2006-09-18 |
2023-08-12 |
human |
| Iu V Karakulov. [Pathogenetic mechanisms of tension headache development]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 106. issue 7. 2006-09-14. PMID:16921720. |
depression and dysfunction of serotonin metabolism play a key role in the pathogenesis of th. |
2006-09-14 |
2023-08-12 |
Not clear |
| Juan Merlo, Bo Gullber. Controlled withdrawal of selective serotonin reuptake inhibitors in elderly patients in nursing homes with no indication of depression--a commentary. European journal of clinical pharmacology. vol 61. issue 4. 2006-09-05. PMID:15918058. |
controlled withdrawal of selective serotonin reuptake inhibitors in elderly patients in nursing homes with no indication of depression--a commentary. |
2006-09-05 |
2023-08-12 |
Not clear |
| Cailan Hou, Fujun Jia, Yi Liu, Lingjiang L. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain research. vol 1095. issue 1. 2006-09-05. PMID:16713589. |
gender-related difference in csf 5-ht implied a female preponderance in major depression to some extent. |
2006-09-05 |
2023-08-12 |
human |
| Tim F Oberlander, William Warburton, Shaila Misri, Jaafar Aghajanian, Clyde Hertzma. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of general psychiatry. vol 63. issue 8. 2006-09-01. PMID:16894066. |
neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. |
2006-09-01 |
2023-08-12 |
Not clear |
| Tim F Oberlander, William Warburton, Shaila Misri, Jaafar Aghajanian, Clyde Hertzma. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of general psychiatry. vol 63. issue 8. 2006-09-01. PMID:16894066. |
prenatal exposure to selective serotonin reuptake inhibitor (ssri) antidepressants and maternal depression both alter neonatal health, and distinguishing the effects of each influence remains challenging. |
2006-09-01 |
2023-08-12 |
Not clear |
| Adrienne E Dorr, Guy Debonne. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. The Journal of pharmacology and experimental therapeutics. vol 318. issue 2. 2006-08-31. PMID:16690723. |
serotonergic [5-hydroxytryptamine (5-ht, serotonin)] and noradrenergic [norepinephrine (ne)] systems are involved in the pathophysiology of depression and in the mechanisms of action of antidepressants. |
2006-08-31 |
2023-08-12 |
Not clear |
| Muneki Tanaka, Toshihiro Nakahara, Tetsuro Muranaga, Shinya Kojima, Daisuke Yasuhara, Hiroaki Ueno, Masamitsu Nakazato, Akio Inu. Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive-behavioral treatment in patients with bulimia nervosa. Hormones and behavior. vol 50. issue 2. 2006-08-29. PMID:16643914. |
we investigated ghrelin and leptin levels, cardiac vagal tone and sympathovagal balance, frequency of sets of binge-eating and vomiting episodes per week and the profile of mood states (poms) depression scale in bn before and after a 16-week administration of the serotonin selective reuptake inhibitor (ssri) paroxetine combined with cognitive-behavioral therapy. |
2006-08-29 |
2023-08-12 |
human |